CD8A and neoplasm: This metabolic shift and PD-L1 expression, can diminish CD8+ T cell and natural killer cell infiltration [88], suppress the memory and antitumor functions of CD8+ T cells [83], and facilitate the infiltration of immunosuppressive cells, ultimately impeding antitumor immunity and promoting tumor progression.